Clinuvel Pharmaceuticals Ltd News

Clinuvel Pharmaceuticals Ltd: Ceasing to be a substantial holder

Aug 23 04:36 ET

Clinuvel Pharmaceuticals Ltd: Becoming a substantial holder

Aug 22 04:57 ET

Clinuvel Pharmaceuticals Ltd: Vitiligo and Operational Update

Aug 20 19:12 ET

Clinuvel Pharmaceuticals Ltd: Annual Results Webinar

Aug 18 19:35 ET

Clinuvel Pharmaceuticals Ltd: Ceasing to be a substantial holder

Aug 15 03:29 ET

Clinuvel Pharmaceuticals Ltd: Becoming a substantial holder

Aug 13 05:19 ET

Clinuvel Pharmaceuticals Ltd: Ceasing to be a substantial holder

Aug 12 18:12 ET

Clinuvel Pharmaceuticals Ltd: Becoming a substantial holder

Aug 8 18:17 ET

Clinuvel Pharmaceuticals Ltd: Change of Company Secretary

Aug 5 19:47 ET

Clinuvel Pharmaceuticals Ltd: Ceasing to be a substantial holder

Aug 1 04:47 ET

Clinuvel Pharmaceuticals Ltd: Becoming a substantial holder

Jul 30 04:11 ET

Clinuvel Pharmaceuticals Ltd: Notification of cessation of securities - CUV

Jul 5 04:16 ET

Clinuvel Pharmaceuticals Ltd: Afamelanotide Assists DNA Repair Response Following UVR

Jul 4 19:40 ET

Clinuvel Pharmaceuticals Ltd: CLINUVEL extends Managing Director Employment Agreement

Jun 27 19:59 ET

Clinuvel Pharmaceuticals Ltd: Change of Company Secretary

Jun 27 19:10 ET

Clinuvel Pharmaceuticals Ltd: SCENESSE European Orphan Drug Designation for VP

Jun 23 18:57 ET

Clinuvel Pharmaceuticals Ltd: afamelanotide in fair-skinned Parkinsons patients

Jun 17 19:27 ET

Clinuvel Pharmaceuticals Ltd: CLINUVEL Newsletter III - June 2024

Jun 10 19:52 ET

Clinuvel Pharmaceuticals Ltd: Update - Notification of buy-back - CUV

Jun 4 19:56 ET

Clinuvel Pharmaceuticals Ltd: CLINUVEL withdraws label expansion for adolescent EPP

Jun 2 19:01 ET